Integra Lifesciences Holdings (IART) Gross Profit Growth (1y) (2010 - 2026)
Integra Lifesciences Holdings (IART) Gross Profit Growth (1y) (2010 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 15.59% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 17.10% |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 10.88% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 12.38% |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 13.54% |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 20.50% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 9.82% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 4.20% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 8.95% |
| 10 | Integra Lifesciences Holdings | 1.29 Bn | 1.02 Bn | 219.74 Mn | 4.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.97% |
| Mar 31, 2026 | 11.60% |
| Dec 31, 2025 | -11.32% |
| Sep 30, 2025 | 3.37% |
| Jun 30, 2025 | -7.34% |
| Mar 31, 2025 | -6.00% |
| Dec 31, 2024 | 9.97% |
| Sep 30, 2024 | -8.29% |
| Jun 30, 2024 | 9.12% |
| Mar 31, 2024 | -11.18% |
| Dec 31, 2023 | -9.43% |
| Sep 30, 2023 | -7.77% |
| Jun 30, 2023 | -16.99% |
| Mar 31, 2023 | -0.51% |
| Dec 31, 2022 | 0.33% |
| Sep 30, 2022 | -2.33% |
| Jun 30, 2022 | 4.48% |
| Mar 31, 2022 | 9.25% |
| Dec 31, 2021 | 3.19% |
| Sep 30, 2021 | 2.96% |